Navigation Links
GeneNews announces management changes
Date:1/20/2009

TORONTO, Jan. 20 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that Mr. Colin T. West has retired from the position of Chief Financial Officer, Vice President of Finance and Treasurer of GeneNews as of December 31, 2008. The Board of Directors has appointed Mr. Sonny Young CA to the role of Vice President of Finance and Treasurer, effective January 1, 2009. Mr. West will remain with the Company until March 31, 2009, to assist in the transition.

"Colin has been a valued member of the management team for the past two years. We thank him and wish him well in his retirement," said Dr. Heiner Dreismann, Lead Director and Interim CEO of GeneNews. "Sonny has been working with GeneNews since April 2006 as a financial consultant. His breadth of experience in financial management makes him well-suited to take on the role of Vice President of Finance and Treasurer."

GeneNews also announced that Mr. Gino Ariano has been appointed to the newly created role of Senior Director, Sentry Business Unit. Mr. Ariano is responsible for the sales and marketing of ColonSentry(TM) throughout Canada.

"Gino's broad experience with the marketing and reimbursement of both medical device and pharmaceutical products will greatly support our efforts to establish and build our Sentry business in Canada, beginning with our lead product, ColonSentry" said Gailina Liew, COO of GeneNews. "We are pleased to welcome Gino to our management team."

Mr. Ariano was at Medtronic Canada for more than 10 years, most recently as a National Sales Manager and, prior to that, Government Relations and Reimbursement Manager. Prior to his tenure at Medtronic, he spent nine years with Glaxo Canada (now GSK) with responsibility for a number of pharmaceutical products.

Mr.Young is the former Director of Corporate Compliance for OccuLogix. Prior to his role at OccuLogix, he was the Controller at Sanofi-Synthelabo and the Director of Financial Accounting at TLC Vision Corp.

    About GeneNews
    --------------

GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. For more information on GeneNews, visit www.genenews.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE GeneNews Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews granted U.S. patent for Chagas disease based on Sentinel Principle(TM) platform
2. GeneNews provides Centocor access to its osteoarthritis program
3. GeneNews to exhibit ColonSentry(TM) at Family Medicine Forum 2008
4. GeneNews rolls out ColonSentry(TM) test in additional Toronto area labs
5. GeneNews appoints Canadian Colorectal Cancer Advisory Board
6. GeneNews restructures operations
7. GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM)
8. GeneNews Announces Second Quarter Results
9. GeneNews launches worlds first blood test for colorectal cancer screening
10. GeneNews announces management changes to support commercialization of ColonSentry(TM)
11. Genenews adds two members to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... , ... August 16, 2017 , ... ... microbe delivery system, announced it has secured $2M in funding from an impressive ... Angels, Carmen Innovations, and SVG Thrive Fund. With this investment, 3Bar is broadening ...
(Date:8/16/2017)... OXFORD, England , Aug. 16, 2017 /PRNewswire/ ... biotech executive search and leadership development, and Virdis Group, global ... created an exclusive alliance that enables clients to leverage the ... "For our clients here in the ... to a diverse population of leadership talent throughout the US, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Nanomedical Diagnostics ... biotherapeutics development, announces the launch of the new NHS Agile biosensor chip ... binding data for a wide range of molecules, including small and large molecules, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Kenall, a leader in sealed ... stay tightly sealed and perform efficiently for years. The downlights are ideal for ... aren't enough, such as: hospitals; behavioral health facilities; cleanrooms; containment areas; food and ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ... of online age and identity verification solutions, announced today ... Identity Conference 2017, May 15 thru May 17, 2017, ... Building and International Trade Center. Identity ... globe and in today,s quickly evolving digital world, defining ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):